Literature DB >> 23039370

Functional outcomes of Vibrant Soundbridge applied on the middle ear windows in comparison with conventional hearing aids.

Bulent Gunduz1, Ahmet Atas, Yıldırım A Bayazıt, Nebil Goksu, Cagıl Gokdogan, Hakan Tutar.   

Abstract

CONCLUSION: Vibrant Soundbridge (VSB) application to the middle ear windows yields better functional outcomes than conventional hearing aids. However, speech discrimination scores obtained with VSB and conventional hearing aids are similar.
OBJECTIVE: To assess audiological outcomes of round and oval window applications of VSB in comparison with conventional hearing aids.
METHODS: Nineteen adult patients were included in the study. The patients had mild to moderate, moderate or moderate to profound conductive or mixed hearing loss. During surgery the floating mass transducer (FMT) was placed on the round (n = 14) or oval (n = 5) window. After the surgery, audiometric evaluation and free field audiometric evaluation of both ears was carried out.
RESULTS: The hearing thresholds in the low frequencies were not significantly different between the conventional hearing aids and VSB. The functional gains obtained with oval and round window approaches were similar except for 500 Hz. The hearing thresholds in the mid and high frequencies were significantly better with VSB than the conventional hearing aids. The functional gain in the low frequencies was not significantly different between VSB and conventional hearing aids. The functional gain in the other frequencies was significantly better with VSB than conventional hearing aids.

Entities:  

Mesh:

Year:  2012        PMID: 23039370     DOI: 10.3109/00016489.2012.702353

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Oval and round window vibroplasty: a comparison of hearing results, risks and failures.

Authors:  Andrea Canale; Federico Dagna; Claudia Cassandro; Pamela Giordano; Federico Caranzano; Michelangelo Lacilla; Roberto Albera
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-11       Impact factor: 2.503

Review 2.  [Active hearing implants in chronic otitis media].

Authors:  S Lailach; C Müller; N Lasurashvili; H Seidler; T Zahnert
Journal:  HNO       Date:  2021-06       Impact factor: 1.284

3.  Functional results after Bonebridge implantation in adults and children with conductive and mixed hearing loss.

Authors:  Torsten Rahne; Ingmar Seiwerth; Gerrit Götze; Cornelia Heider; Florian Radetzki; Michael Herzog; Stefan K Plontke
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-26       Impact factor: 2.503

Review 4.  [Differential indication of active middle ear implants].

Authors:  K Braun; H-P Zenner; N Friese; A Tropitzsch
Journal:  HNO       Date:  2015-06       Impact factor: 1.284

Review 5.  Efficacy of Auditory Implants for Patients With Conductive and Mixed Hearing Loss Depends on Implant Center.

Authors:  Ad Snik; Hannes Maier; Bill Hodgetts; Martin Kompis; Griet Mertens; Paul van de Heyning; Thomas Lenarz; Arjan Bosman
Journal:  Otol Neurotol       Date:  2019-04       Impact factor: 2.311

6.  Vibrant Soundbridge and Bone Conduction Hearing Aid in Patients with Bilateral Malformation of External Ear.

Authors:  Maria Fernanda Capoani Garcia Mondelli; Thais Cristina Barbosa Mariano; Heitor Marques Honório; Rubens Vuono de Brito
Journal:  Int Arch Otorhinolaryngol       Date:  2015-10-28

7.  Round Window Application of an Active Middle Ear Implant: A Comparison With Hearing Aid Usage in Japan.

Authors:  Satoshi Iwasaki; Shin-Ichi Usami; Haruo Takahashi; Yukihiko Kanda; Tetsuya Tono; Katsumi Doi; Kozo Kumakawa; Kiyofumi Gyo; Yasushi Naito; Sho Kanzaki; Noboru Yamanaka; Kimitaka Kaga
Journal:  Otol Neurotol       Date:  2017-07       Impact factor: 2.311

Review 8.  ACTIVE MIDDLE EAR VIBRANT SOUNDBRIDGE SOUND IMPLANT.

Authors:  Alan Pegan; Mihael Ries; Jakov Ajduk; Vladimir Bedeković; Mirko Ivkić; Robert Trotić
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.